Athira Pharma Inc 内部交易概览
最近18个月交易的高管股东 | 交易次数 | 净买入(股) |
---|---|---|
Andrew Gengos | 4 | 77,596 |
Mark James Litton | 2 | -9,640 |
Kevin Church | 2 | -4,824 |
Rachel Lenington | 2 | -4,824 |
Mark Worthington | 2 | -4,824 |
James A Johnson | 1 | 5,000 |
交易分段汇总 | 买入数量 | 卖出数量 | 净买入(股) |
---|---|---|---|
最近1个月 | 0 | 0 | 0 |
最近3个月 | 0 | 0 | 0 |
最近6个月 | 605,686 | 22,908 | 582,778 |
最近12个月 | 685,698 | 22,908 | 662,790 |
最近18个月 | 800,698 | 26,528 | 774,170 |
Athira Pharma Inc 内部交易
Athira Pharma Inc 最新内部交易
Andrew Gengos | CFO & CHIEF BUSINESS OFFICER | 2024-01-05 | 卖出 | 1,208 | 83,804 |
$2.91
|
-32.99%
|
Rachel Lenington | COO | 2024-01-05 | 卖出 | 2,412 | 13,395 |
$2.91
|
-32.99%
|
Kevin Church | CHIEF SCIENTIFIC OFFICER | 2024-01-05 | 卖出 | 2,412 | 80,256 |
$2.91
|
-32.99%
|
Rachel Lenington | COO & CDO | 2024-01-05 | 卖出 | 2,412 | 13,395 |
$2.91
|
-32.99%
|
Mark James Litton | CEO | 2024-01-05 | 卖出 | 4,820 | 164,086 |
$2.91
|
-32.99%
|
Mark Worthington | GENERAL COUNSEL | 2024-01-05 | 卖出 | 2,412 | 34,452 |
$2.91
|
-32.99%
|
Mark Worthington | General Counsel | 2024-01-05 | 卖出 | 2,412 | 34,452 |
$2.91
|
-32.99%
|
Mark James Litton | CEO | 2024-01-05 | 卖出 | 4,820 | 164,086 |
$2.91
|
-32.99%
|
Perceptive Life Sciences Master Fund Ltd | Director, 10% Owner | 2023-12-29 | 买入 | 605,686 | 5,402,964 |
$2.42
|
-19.42%
|
Andrew Gengos | See Below | 2023-06-07 | 买入 | 15,000 | 80,012 |
$3.43
|
-43.15%
|